8-K 1 a10-9969_18k.htm 8-K

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): May 7, 2010

 

CardioNet, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33993

 

33-0604557

(State or other jurisdiction

 

(Commission

 

(I.R.S. Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

 

 

 

227 Washington Street #210
Conshohocken, PA

 

19428

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (610) 729-7000

 

Not Applicable
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07                                             Submission of Matters to a Vote of Security Holders.

 

On May 7, 2010, CardioNet, Inc. (the “Company”) held its 2010 annual meeting of stockholders (the “Annual Meeting”).  At the Annual Meeting, the Company’s stockholders elected all three nominees for director and approved the Company’s other proposal.  The nominees and the other proposal are described in detail in the Company’s Definitive Proxy Statement.

 

Proposal 1

 

The Company’s stockholders re-elected the following three members of the Board of Directors:

 

 

 

Votes For

 

Votes Withheld

 

Broker Non-Votes

 

Eric N. Prystowsky,M.D.

 

10,149,309

 

4,618,393

 

5,828,335

 

Rebecca W. Rimel

 

14,575,467

 

192,235

 

5,828,335

 

Robert J. Rubin, M.D

 

9,079,732

 

5,687,970

 

5,828,335

 

 

Proposal 2

 

The Company’s stockholders ratified the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP, Independent Registered Public Accounting Firm, as independent auditors of the Company for the fiscal year ending December 31, 2010.

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

20,494,629

 

81,928

 

19,480

 

N/A

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CardioNet, Inc.

 

 

 

 

May 12, 2010

By:

/s/ Heather Getz

 

 

Name:

Heather Getz, CPA

 

 

Title:

Chief Financial Officer

 

3